Cipla, Infosys, Wheels India, Oberoi Realty, Huhtamaki PPL

Cipla has received final approval for its abbreviated new drug application for Efavirenz tablets 600mg from the USFDA. It is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults

Infosys expands footprint in france by establishing state-of-the-art digital center of excellence in Marseille.Brigade Enterprises board meeting on June 22 to consider proposal for fund raising by issue of non-convertible debentures

Wheels India's board, on June 22, may consider issue of bonus shares

DCM Shriram to buyback 55.55 lakh equity shares at Rs 450 each

Brickwork Ratings India revised ratings of debt instruments of IFCI

Kansai Nerolac Paints has entered into a share purchase agreement to acquire 55 percent of the paid-up equity of RAK Paints, Bangladesh, for a total consideration of Bangladeshi Taka (BDT) 57.26 crore (approximately Rs 45.81 crore)

Read more--Stocks update